FDA Adverse Event Injury Summary report: N

MICOR LENS FRAGMENTATION SYSTEM

MDR report key: 20164644 · Received September 6, 2024

Report

Report Number
3012123033-2024-00008
Event Type
Injury
Date Received
September 6, 2024
Date of Event
August 8, 2024
Report Date
September 6, 2024
Manufacturer
CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC.
Product Code
HQC
UDI-DI
00860000122368
PMA / PMN Number
K222236
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE MICOR EXTRACTOR WAS DISCARDED BY THE CUSTOMER AT THE TIME OF THE EVENT AND IS NOT AVAILABLE FOR EVALUATION. NO DEVICE IDENTIFIERS ARE AVAILABLE. THE SURGEON PROVIDED THEIR MEDICAL OPINION IN SECTION B5 DESCRIBING THE FACTORS THAT MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. WHILE THE DEVICE WAS NOT AVAILABLE FOR TESTING, BASED ON REVIEW OF THE DEVICE DESIGN HISTORY FILE, THE MICOR SYSTEM WAS DESIGNED TO BUILD VACUUM TO MAXIMUM POTENTIAL IN THE SAME TIMEFRAME AS PHACOEMULSIFICATION. HOWEVER, THE MICOR DOES NOT HAVE A COMPUTER DISPLAY AND WAS NOT DESIGNED WITH INDICATORS FOR METRICS SUCH VACUUM LEVEL, FLUIDICS, ETC. IMPORTANTLY, THE USER HAS THE ABILITY TO BREAK VACUUM AT ANY TIME DURING LENS EXTRACTION TO MITIGATE THE RISK OF CAPSULAR BAG DAMAGE. THE DEVICE LABELING IDENTIFIES CAPSULAR RUPTURE AS AN INHERENT SAFETY RISK. MANUFACTURER'S REFERENCE #: (B)(4).

Description of Event or Problem · 0

A PATIENT UNDERWENT CATARACT SURGERY IN THE LEFT EYE ON (B)(6) 2024 WHERE THE MICOR LENS FRAGMENTATION SYSTEM WAS USED TO REMOVE THE CATARACTOUS LENS FRAGMENTS. THE SURGEON EXPERIENCED A SMALL HOLE IN THE POSTERIOR CAPSULE DURING IRRIGATION AND ASPIRATION OF CORTEX. THE ANTERIOR HYALOID REMAINED INTACT AND THERE WAS NO VITREOUS FLUID LOSS. SURGICAL TECHNIQUE WAS EMPLOYED APPROPRIATELY, I.E., NOT ALLOWING CAPSULAR BAG TO BOW FORWARD. THE SURGEON ATTRIBUTED THE EVENT TO THE MICOR DEVICE CITING "SNAPPINESS" WHICH IS FURTHER CLARIFIED BELOW. "WHILE THE EVENT WAS ATTRIBUTABLE TO THE FLUIDICS OF THE DEVICE, THE FACT THAT THE [MICOR EXTRACTOR] TIP DOES NOT HAVE SHARP EDGES ALSO CONTRIBUTED TO THE SMALL SIZE OF THE HOLE, THE FACT THAT THE TEAR DID NOT EXTEND, AND MY ABILITY TO PLACE A ONE PIECE TORIC MULTIFOCAL IOL IN THE BAG AS PLANNED. THERE WAS A THIN EPINUCLEAR PLATE [OF THE CATARACT] PRESENT. IN BOTH PHACO[EMULSIFICATION] AND MICOR, WHEN YOU REACH FOR A THIN REMAINING PIECE, THERE IS A RISK OF THE DEVICE BUILDING VACUUM AND POPPING THROUGH THE REMAINING [CATARACT] PIECE AND THEN INTERACTING WITH THE POSTERIOR CAPSULE, THEREBY CAUSING A TEAR. THERE WAS A CLINICAL DECISION MADE TO REACH FOR THE REMAINING THIN PIECE THAT CONTRIBUTED TO THE ADVERSE EVENT. WHILE I ATTRIBUTE THE QUICK BUILD IN VACUUM TO THE DEVICE, THE ADVERSE EVENT WAS ALSO ATTRIBUTABLE TO SURGEON CLINICAL DECISION MAKING. ON THE OTHER HAND, I CAN SAY WITH ABSOLUTE CONFIDENCE THAT IF A SIMILAR SITUATION HAD OCCURRED WITH PHACO (PC TEAR FROM REACHING FOR AN EPINUCLEAR PIECE), THAT THE SEQUELAE WOULD HAVE BEEN VERY DIFFERENT, AND WORSE. WHENEVER THE PHACO NEEDLE CREATES A PC [POSTERIOR CAPSULE] TEAR, THE HOLE HAS JAGGED EDGES AND SO IT IMMEDIATELY EXPANDS UNDER THE HIGH FLOW STATE. WITH MICOR, THE HOLE SEEMS TO NEVER EXPAND BECAUSE OF THE VERY SMOOTH EDGES AND THE LOW FLOW OF IRRIGATION. HAD I BEEN USING PHACO, THE PATIENT WOULD HAVE ENDED UP WITH A 3-PIECE MONOFOCAL IOL [INTRAOCULAR LENS] IN THE SULCUS, DESPITE HAVING PAID FOR A PREMIUM IOL. BECAUSE OF THE NATURE OF THE PC TEAR, I WAS STILL ABLE TO PLACE A SINGLE PIECE MULTIFOCAL TORIC IOL IN THE BAG. I'VE NEVER BEEN ABLE TO SAVE A SIMILAR SITUATION TO THIS WITH PHACO LIKE I DID. MY PRESUMPTION IS THAT IT WAS THE MICOR'S OTHER FEATURES (LOW FLOW AND SMOOTH TIP EDGES) THAT MADE A VERY GOOD SITUATION OUT OF AN ADVERSE EVENT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1489727 MICOR LENS FRAGMENTATION SYSTEM PHACOFRAGMENTATION SYSTEM HQC CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC. FG-50621 00860000122368

Patients

Seq Age Sex Outcome Treatment
1 79 YR Unknown Disability